Ceftriaxone Treatment Weakens Long-Term Synaptic Potentiation in the Hippocampus of Young Rats

Disrupted glutamate clearance in the synaptic cleft leads to synaptic dysfunction and neurological diseases. Decreased glutamate removal from the synaptic cleft is known to cause excitotoxicity. Data on the physiological effects of increased glutamate clearance are contradictory. This study investig...

Full description

Bibliographic Details
Main Authors: Tatyana Y. Postnikova, Sergey L. Malkin, Maria V. Zakharova, Ilya V. Smolensky, Olga E. Zubareva, Aleksey V. Zaitsev
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/16/8417
_version_ 1797523637380579328
author Tatyana Y. Postnikova
Sergey L. Malkin
Maria V. Zakharova
Ilya V. Smolensky
Olga E. Zubareva
Aleksey V. Zaitsev
author_facet Tatyana Y. Postnikova
Sergey L. Malkin
Maria V. Zakharova
Ilya V. Smolensky
Olga E. Zubareva
Aleksey V. Zaitsev
author_sort Tatyana Y. Postnikova
collection DOAJ
description Disrupted glutamate clearance in the synaptic cleft leads to synaptic dysfunction and neurological diseases. Decreased glutamate removal from the synaptic cleft is known to cause excitotoxicity. Data on the physiological effects of increased glutamate clearance are contradictory. This study investigated the consequences of ceftriaxone (CTX), an enhancer of glutamate transporter 1 expression, treatment on long-term synaptic potentiation (LTP) in the hippocampus of young rats. In this study, 5-day administration of CTX (200 mg/kg) significantly weakened LTP in CA3-CA1 synapses. As shown by electrophysiological recordings, LTP attenuation was associated with weakening of N-Methyl-D-aspartate receptor (NMDAR)-dependent signaling in synapses. However, PCR analysis did not show downregulation of NMDAR subunits or changes in the expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) subunits. We assume that extracellular burst stimulation activates fewer synapses in CTX-treated animals because increased glutamate reuptake results in reduced spillover, and neighboring synapses do not participate in neurotransmission. Attenuation of LTP was not accompanied by noticeable behavioral changes in the CTX group, with no behavioral abnormalities observed in the open field test or Morris water maze test. Thus, our experiments show that increased glutamate clearance can impair long-term synaptic plasticity and that this phenomenon can be considered a potential side effect of CTX treatment.
first_indexed 2024-03-10T08:45:53Z
format Article
id doaj.art-6bcbe3ccc0ab428186860331366cd400
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T08:45:53Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-6bcbe3ccc0ab428186860331366cd4002023-11-22T07:55:00ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-08-012216841710.3390/ijms22168417Ceftriaxone Treatment Weakens Long-Term Synaptic Potentiation in the Hippocampus of Young RatsTatyana Y. Postnikova0Sergey L. Malkin1Maria V. Zakharova2Ilya V. Smolensky3Olga E. Zubareva4Aleksey V. Zaitsev5Sechenov Institute of Evolutionary Physiology and Biochemistry of RAS, 44, Toreza Prospekt, 194223 Saint Petersburg, RussiaSechenov Institute of Evolutionary Physiology and Biochemistry of RAS, 44, Toreza Prospekt, 194223 Saint Petersburg, RussiaSechenov Institute of Evolutionary Physiology and Biochemistry of RAS, 44, Toreza Prospekt, 194223 Saint Petersburg, RussiaSechenov Institute of Evolutionary Physiology and Biochemistry of RAS, 44, Toreza Prospekt, 194223 Saint Petersburg, RussiaSechenov Institute of Evolutionary Physiology and Biochemistry of RAS, 44, Toreza Prospekt, 194223 Saint Petersburg, RussiaSechenov Institute of Evolutionary Physiology and Biochemistry of RAS, 44, Toreza Prospekt, 194223 Saint Petersburg, RussiaDisrupted glutamate clearance in the synaptic cleft leads to synaptic dysfunction and neurological diseases. Decreased glutamate removal from the synaptic cleft is known to cause excitotoxicity. Data on the physiological effects of increased glutamate clearance are contradictory. This study investigated the consequences of ceftriaxone (CTX), an enhancer of glutamate transporter 1 expression, treatment on long-term synaptic potentiation (LTP) in the hippocampus of young rats. In this study, 5-day administration of CTX (200 mg/kg) significantly weakened LTP in CA3-CA1 synapses. As shown by electrophysiological recordings, LTP attenuation was associated with weakening of N-Methyl-D-aspartate receptor (NMDAR)-dependent signaling in synapses. However, PCR analysis did not show downregulation of NMDAR subunits or changes in the expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) subunits. We assume that extracellular burst stimulation activates fewer synapses in CTX-treated animals because increased glutamate reuptake results in reduced spillover, and neighboring synapses do not participate in neurotransmission. Attenuation of LTP was not accompanied by noticeable behavioral changes in the CTX group, with no behavioral abnormalities observed in the open field test or Morris water maze test. Thus, our experiments show that increased glutamate clearance can impair long-term synaptic plasticity and that this phenomenon can be considered a potential side effect of CTX treatment.https://www.mdpi.com/1422-0067/22/16/8417long-term potentiationNMDA receptorhippocampusEAAT2memory
spellingShingle Tatyana Y. Postnikova
Sergey L. Malkin
Maria V. Zakharova
Ilya V. Smolensky
Olga E. Zubareva
Aleksey V. Zaitsev
Ceftriaxone Treatment Weakens Long-Term Synaptic Potentiation in the Hippocampus of Young Rats
International Journal of Molecular Sciences
long-term potentiation
NMDA receptor
hippocampus
EAAT2
memory
title Ceftriaxone Treatment Weakens Long-Term Synaptic Potentiation in the Hippocampus of Young Rats
title_full Ceftriaxone Treatment Weakens Long-Term Synaptic Potentiation in the Hippocampus of Young Rats
title_fullStr Ceftriaxone Treatment Weakens Long-Term Synaptic Potentiation in the Hippocampus of Young Rats
title_full_unstemmed Ceftriaxone Treatment Weakens Long-Term Synaptic Potentiation in the Hippocampus of Young Rats
title_short Ceftriaxone Treatment Weakens Long-Term Synaptic Potentiation in the Hippocampus of Young Rats
title_sort ceftriaxone treatment weakens long term synaptic potentiation in the hippocampus of young rats
topic long-term potentiation
NMDA receptor
hippocampus
EAAT2
memory
url https://www.mdpi.com/1422-0067/22/16/8417
work_keys_str_mv AT tatyanaypostnikova ceftriaxonetreatmentweakenslongtermsynapticpotentiationinthehippocampusofyoungrats
AT sergeylmalkin ceftriaxonetreatmentweakenslongtermsynapticpotentiationinthehippocampusofyoungrats
AT mariavzakharova ceftriaxonetreatmentweakenslongtermsynapticpotentiationinthehippocampusofyoungrats
AT ilyavsmolensky ceftriaxonetreatmentweakenslongtermsynapticpotentiationinthehippocampusofyoungrats
AT olgaezubareva ceftriaxonetreatmentweakenslongtermsynapticpotentiationinthehippocampusofyoungrats
AT alekseyvzaitsev ceftriaxonetreatmentweakenslongtermsynapticpotentiationinthehippocampusofyoungrats